The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ALBAN: An open label, randomized, phase III trial, evaluating efficacy of atezolizumab in addition to one year BCG (bacillus Calmette-Guerin) bladder instillation in BCG-naive patients with high-risk nonmuscle invasive bladder cancer (AFU-GETUG 37).
 
Morgan Roupret
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
Yann Neuzillet
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bouchara Recordati; Bristol-Myers Squibb; Ipsen; MSD; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bouchara Recordati; Ipsen; MSD
 
Aurelie Bertaut
No Relationships to Disclose
 
Geraldine Pignot
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen
Speakers' Bureau - Bouchara Recordati; Bristol-Myers Squibb; Ipsen; Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Janssen; MSD; Pfizer; Roche; Takeda
 
Nadine Houede
No Relationships to Disclose
 
Stephane Champiat
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche
 
Soazig Nénan-Le Ficher
No Relationships to Disclose
 
Maggy Chausson
No Relationships to Disclose
 
Yohann Loriot
Honoraria - Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Incyte; Janssen; Janssen (Inst); MSD Oncology; MSD Oncology (Inst); Roche; Seagen
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); CureVac (Inst); Exelixis (Inst); Incyte (Inst); Janssen Oncology (Inst); Medivation (Inst); MSD Oncology (Inst); Oncogenex (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche